Lincare a linde company
At the time the tender offer is commenced, Linde will file a tender offer statement with the United States Securities and Exchange Commission (the “SEC”). The tender offer described herein has not yet commenced, and this material is neither an offer to purchase nor a solicitation of an offer to sell shares of Lincare Holdings Inc. The acquisition loan will be refinanced by debt and equity issuances. The funding of the transaction will be done by an acquisition loan in the total amount of USD 4.5 bn and through available cash. Completion of the offer and merger is subject to receipt of regulatory approvals and other customary closing conditions. Closing is expected for the third quarter of fiscal year 2012. The planned acquisition has a total transaction volume of approximately USD 4.6 billion. shareholders of USD 41.50 per common share, followed by a merger. by submitting a cash offer to the Lincare Holdings Inc. Linde intends to acquire all outstanding shares of Lincare Holdings Inc. Medicare reimbursement pressure will continue to be an overhang on the industry and Linde will have to deal with the problem as reimbursement pressure is not expected to stabilize soon.Munich, 1 July 2012 - Linde has signed a merger agreement with Lincare Holdings Inc., a US-based homecare health company. However, Lincare derives a major portion of its revenue from government sources and is therefore vulnerable to reimbursement rate cuts and uncertainties surrounding the competitive bidding program. In 2011, Linde's health care division generated revenues of €1.2 billion. Linde's health care division provides medical gas and pharmaceutical offerings for the treatment of a variety of clinical conditions such as aerosol therapy, oxygen therapy, asthma, anesthesia, chronic obstructive pulmonary disease, sleep apnea and pain. Also, Linde's subsidiary LifeGas has been doing business with Lincare for several years now. was through its Homecare business, which supplied products to other home health care companies in the U.S. Prior to the Lincare acquisition, Linde's connection with the U.S. The merger will enable Linde to become the global leader in health care offerings within the gases industry. Two-thirds of the €12 billion global health care industry is dedicated to homecare products with an annual growth rate of roughly 6%. The company offers services and equipment to more than 800,000 clients across the U.S. health care market, which is the largest in the world.įlorida-based Lincare is a leading provider of oxygen and other respiratory therapy services to patients at home. With this acquisition, Linde will be able to double its sales in the North American Gases business and target the €4 billion U.S. home health care market are Gentiva Health Services Inc. The merger should be accretive for Linde as it will be able to expand its market base significantly, especially in the U.S. Linde utilized its "top-up" option to acquire the additional shares directly from the company at the same rate of $41.50, as offered in the tender.Īcquisition will Significantly Boost Linde's U.S. Linde subsequently purchased the rest of the issued and outstanding shares through a short-form merger. Linde completed a tender offer on August 8, 2012, during which it bought roughly 88.85% of Lincare's common stocks for $41.50 per share in cash. Following the acquisition, Lincare has been incorporated into Linde as a fully-owned subsidiary. The Linde Group recently completed its acquisition of Lincare Holdings Inc., a leading provider of oxygen and respiratory therapies. Institutional Distribution Intelligence.Non-Traditional Exchanges & New Markets.Directors’ and Officers’ Questionnaires.